XENON XE 133-V.S.S.
LOE ApproachingNDAINHALATIONGAS
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon Xe-133 is an inhaled radioactive gas indicated for pulmonary ventilation imaging to assess lung function and detect perfusion abnormalities. It is a diagnostic imaging agent, not a therapeutic drug, used in nuclear medicine to visualize regional ventilation patterns in the lungs.
LOE Approaching
Mature diagnostic imaging product with LOE approaching; commercial teams likely focused on transition planning and retention of institutional relationships rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career roles linked to Xenon Xe-133 are minimal (0 linked positions) and primarily operational or account-focused rather than growth-oriented. Working on this product offers stability in a mature market but limited advancement or innovation opportunities; ideal for professionals seeking niche expertise in diagnostic imaging or end-of-life portfolio management.
Product Manager (Diagnostics)
Worked on XENON XE 133-V.S.S. at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.